A large study of Veterans Affairs (VA) patients in JAMA Internal Medicine shows that, during the 2022 to 2023 season, having ...

The 30-day risks of hospitalization were 17.5%, 15.9%, and 14.4% for COVID, influenza, and RSV, respectively, during the 2022 ...

Fact checked by Nick Blackmer Cases of respiratory syncytial virus (RSV) have peaked in many areas of the United States, ...

RSV is usually contagious for three to eight days. A patient also may be contagious a day or two before experiencing symptoms ...

The U.S. is seeing a "quad-demic" as cases of COVID-19, flu, RSV and norovirus spread at the same time. Experts said this is ...

Nearly 80% of infants born in a California health system were exposed to nirsevimab or the maternal respiratory syncytial ...

Flu season is here in California, but other illnesses are in full swing in the Golden State. Here are the symptoms and how ...

The study, published Jan. 20 in The Lancet Infectious Diseases, found the vaccine to be 78% effective against RSV infection, 79% effective against emergency department and urgent care visits and 80% ...

This cohort study showed that, during the 2022 to 2023 season, infection with SARS-CoV-2 was associated with more severe disease outcomes than influenza or respiratory syncytial virus (RSV), whereas ...

Bon Secours and Prisma Health are implementing new visitor restrictions as cases of influenza and respiratory illnesses rise ...

The South Carolina Department of Public Health announced Friday that the state has suffered its first pediatric flu-related death of the season.